Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
astipal
medochemie ltd. - itoprido hidrochloridas - plėvele dengtos tabletės - 50 mg - itropride
Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
deep heat
the mentholatum company (ireland) limited - metilsalicilatas/levomentolis ir raceminis mentolis/eukaliptų (eucalyptus) eterinis aliejus/terpentino eterinis aliejus - kremas - 128 mg/59,1 mg/19,7 mg/14,7 mg/g - various
Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
deep relief
the mentholatum company (ireland) limited - ibuprofenas/levomentolis - gelis - 50 mg/30 mg/g - various
Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
azalonum
medochemie ltd. - cinarizinas/dimenhidrinatas - tabletės - 20 mg/40 mg - cinnarizine, combinations
Unión Europea -
lituano -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologai - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Unión Europea -
lituano -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Unión Europea -
lituano -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
asitus
sia ingen pharma - acetilcisteinas - milteliai geriamajam tirpalui - 600 mg - acetylcysteine
Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
contractubex
merz pharmaceuticals gmbh - svogūnų (allium cepa linne) skystasis ekstraktas (1,5-2,2:1)/heparino natrio druska/alantoinas - gelis - 100 mg/50 tv/10 mg/g - other cicatrizants
Lituania -
lituano -
SMCA (Valstybinė vaistų kontrolės tarnyba)
helituspan
sopharma ad - gebenių (hedera helix) lapų sausasis ekstraktas (5-7,5:1) - sirupas - 7 mg/ml - hederae helicis folium